Plaque-associated local toxicity increases over the clinical course of Alzheimer disease

American Journal of Pathology

Volumn 186, Issue 2, 2016, Pages 375-384

  Serrano Pozo, Alberto ^a,b   Betensky, Rebecca A ^a,c   Frosch, Matthew P ^a   Hyman, Bradley T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; CD68 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOPROTEIN IB ALPHA; PROTEIN; SMI312 PROTEIN; UNCLASSIFIED DRUG; AMYLOID;

AGED; ALLELE; ALZHEIMER DISEASE; AMYLOID PLAQUE; ANTHROPOMETRIC PARAMETERS; ARTICLE; ASTROCYTE; CELL SHAPE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; FEMALE; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HISTOGRAM; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MICROGLIA; NEOCORTEX; NERVE FIBER DEGENERATION; NEURITE; NEUROPIL; NEUROTOXICITY; PRIORITY JOURNAL; TEMPORAL CORTEX; TUMOR SPHEROID; COGNITION; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; NEUROFIBRILLARY TANGLE; PATHOLOGY; PHYSIOLOGY; PROCEDURES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID; ASTROCYTES; COGNITION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MIDDLE AGED; NEURITES; NEUROFIBRILLARY TANGLES; PLAQUE, AMYLOID;

EID: 84955277695     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2015.10.010     Document Type: Article

References (74)

1. A. Serrano-Pozo, M.P. Frosch, E. Masliah, and B.T. Hyman Neuropathological alterations in Alzheimer disease Cold Spring Harb Perspect Med 1 2011 a006189
2. D.J. Selkoe The molecular pathology of Alzheimer's disease Neuron 6 1991 487 498
3. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356
4. M. Ingelsson, H. Fukumoto, K.L. Newell, J.H. Growdon, E.T. Hedley-Whyte, M.P. Frosch, M.S. Albert, B.T. Hyman, and M.C. Irizarry Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain Neurology 62 2004 925 931
5. A. Serrano-Pozo, M.L. Mielke, T. Gómez-Isla, R.A. Betensky, J.H. Growdon, M.P. Frosch, and B.T. Hyman Reactive glia not only associates with plaques but also parallels tangles in Alzheimer's disease Am J Pathol 179 2011 1373 1384
6. A. Serrano-Pozo, M.L. Mielke, A. Muzitansky, T. Gómez-Isla, J.H. Growdon, B.J. Bacskai, R.A. Betensky, M.P. Frosch, and B.T. Hyman Stable size distribution of amyloid plaques over the course of Alzheimer disease J Neuropathol Exp Neurol 71 2012 694 701
7. C.R. Jack Jr., D.S. Knopman, W.J. Jagust, L.M. Shaw, P.S. Aisen, M.W. Weiner, R.C. Petersen, and J.Q. Trojanowski Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade Lancet Neurol 9 2010 119 128
8. C.R. Jack Jr., D.S. Knopman, W.J. Jagust, R.C. Petersen, M.W. Weiner, P.S. Aisen, L.M. Shaw, P. Vemuri, H.J. Wiste, S.D. Weigand, T.G. Lesnick, V.S. Pankratz, M.C. Donohue, and J.Q. Trojanowski Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers Lancet Neurol 12 2013 207 216
9. R.J. Bateman, C. Xiong, T.L. Benzinger, A.M. Fagan, A. Goate, N.C. Fox, D.S. Marcus, N.J. Cairns, X. Xie, T.M. Blazey, D.M. Holtzman, A. Santacruz, V. Buckles, A. Oliver, K. Moulder, P.S. Aisen, B. Ghetti, W.E. Klunk, E. McDade, R.N. Martins, C.L. Masters, R. Mayeux, J.M. Ringman, M.N. Rossor, P.R. Schofield, R.A. Sperling, S. Salloway, J.C. Morris Dominantly Inherited Alzheimer Network Clinical and biomarker changes in dominantly inherited Alzheimer's disease N Engl J Med 367 2012 795 804
10. M. Meyer-Luehmann, T.L. Spires-Jones, C. Prada, M. Garcia-Alloza, A. de Calignon, A. Rozkalne, J. Koenigsknecht-Talboo, D.M. Holtzman, B.J. Bacskai, and B.T. Hyman Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease Nature 451 2008 720 724
11. G.M. McKhann, D.S. Knopman, H. Chertkow, B.T. Hyman, C.R. Jack Jr., C.H. Kawas, W.E. Klunk, W.J. Koroshetz, J.J. Manly, R. Mayeux, R.C. Mohs, J.C. Morris, M.N. Rossor, P. Scheltens, M.C. Carrillo, B. Thies, S. Weintraub, and C.H. Phelps The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 263 269
12. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944
13. B.T. Hyman, C.H. Phelps, T.G. Beach, E.H. Bigio, N.J. Cairns, M.C. Carrillo, D.W. Dickson, C. Duyckaerts, M.P. Frosch, E. Masliah, S.S. Mirra, P.T. Nelson, J.A. Schneider, D.R. Thal, B. Thies, J.Q. Trojanowski, H.V. Vinters, and T.J. Montine National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease Alzheimers Dement 8 2012 1 13
14. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease Neurobiol Aging 18 1997 S1 S2
15. T.J. Montine, C.H. Phelps, T.G. Beach, E.H. Bigio, N.J. Cairns, D.W. Dickson, C. Duyckaerts, M.P. Frosch, E. Masliah, S.S. Mirra, P.T. Nelson, J.A. Schneider, D.R. Thal, J.Q. Trojanowski, H.V. Vinters, B.T. Hyman National Institute on Aging, Alzheimer's Association National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach Acta Neuropathol 123 2012 1 11
16. A. Serrano-Pozo, A. Muzikansky, T. Gómez-Isla, J.H. Growdon, R.A. Betensky, M.P. Frosch, and B.T. Hyman Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in Alzheimer disease J Neuropathol Exp Neurol 72 2013 462 471
17. A. Serrano-Pozo, T. Gómez-Isla, J.H. Growdon, M.P. Frosch, and B.T. Hyman A phenotypic change but not proliferation underlies glial responses in Alzheimer disease Am J Pathol 182 2013 2332 2344
18. A. Serrano-Pozo, C.M. William, I. Ferrer, E. Uro-Coste, M.-B. Delisle, C.-A. Maurage, C. Hock, R.M. Nitsch, E. Masliah, J.H. Growdon, M.P. Frosch, and B.T. Hyman Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology Brain 133 2010 1312 1327
19. R.B. Knowles, C. Wyart, S.V. Buldyrev, L. Cruz, B. Urbanc, M.E. Hasselmo, H.E. Stanley, and B.T. Hyman Plaque-induced neurite abnormalities: implications for disruption of neural networks in Alzheimer's disease Proc Natl Acad Sci U S A 96 1999 5274 5279
20. R. Le, L. Cruz, B. Urbanc, R.B. Knowles, K. Hsiao-Ashe, K. Duff, M.C. Irizarry, H.E. Stanley, and B.T. Hyman Plaque-induced abnormalities in neurite geometry in transgenic models of Alzheimer disease: implications for neural system disruption J Neuropathol Exp Neurol 60 2001 753 758
21. J.D. D'Amore, S.T. Kajdasz, M.E. McLellan, B.J. Bacskai, E.A. Stern, and B.T. Hyman In vivo multiphoton imaging of a transgenic mouse model of Alzheimer disease reveals marked thioflavine-S-associated alterations in neurite trajectories J Neuropathol Exp Neurol 62 2003 137 145
22. T.L. Spires, M. Meyer-Luehmann, E.A. Stern, P.J. McLean, J. Skoch, P.T. Nguyen, B.J. Bacskai, and B.T. Hyman Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy J Neurosci 25 2005 7278 7287
23. T. Gómez-Isla, R. Hollister, H. West, S. Mui, J.H. Growdon, R.C. Petersen, J.E. Parisi, and B.T. Hyman Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease Ann Neurol 41 1997 17 24
24. S. Datta, and G.A. Satten Rank-sum tests for clustered data J Am Stat Assoc 100 2005 908 915
25. D.M. Holtzman, J. Herz, and G. Bu Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease Cold Spring Harb Perspect Med 2 2012 a006312
26. H.-Y. Wu, E. Hudry, T. Hashimoto, K. Kuchibhotla, A. Rozkalne, Z. Fan, T. Spires-Jones, H. Xie, M. Arbel-Ornath, C.L. Grosskreutz, B.J. Bacskai, and B.T. Hyman Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation J Neurosci 30 2010 2636 2649
27. M. Garcia-Alloza, S.A. Dodwell, M. Meyer-Luehmann, B.T. Hyman, and B.J. Bacskai Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model J Neuropathol Exp Neurol 65 2006 1082 1089
28. W.S. Griffin, J.G. Sheng, G.W. Roberts, and R.E. Mrak Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution J Neuropathol Exp Neurol 54 1995 276 281
29. S.E. Stoltzner, T.J. Grenfell, C. Mori, K.E. Wisniewski, T.M. Wisniewski, D.J. Selkoe, and C.A. Lemere Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease Am J Pathol 156 2000 489 499
30. J.H. Su, B.J. Cummings, and C.W. Cotman Plaque biogenesis in brain aging and Alzheimer's disease. II. Progressive transformation and developmental sequence of dystrophic neurites Acta Neuropathol 96 1998 463 471
31. S.T. DeKosky, and S.W. Scheff Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity Ann Neurol 27 1990 457 464
32. R.D. Terry, E. Masliah, D.P. Salmon, N. Butters, R. DeTeresa, R. Hill, L.A. Hansen, and R. Katzman Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment Ann Neurol 30 1991 572 580
33. L.M. Bierer, P.R. Hof, D.P. Purohit, L. Carlin, J. Schmeidler, K.L. Davis, and D.P. Perl Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease Arch Neurol 52 1995 81 88
34. T. Gómez-Isla, J.L. Price, D.W. McKeel Jr., J.C. Morris, J.H. Growdon, and B.T. Hyman Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease J Neurosci 16 1996 4491 4500
35. P. Giannakopoulos, F.R. Herrmann, T. Bussière, C. Bouras, E. Kövari, D.P. Perl, J.H. Morrison, G. Gold, and P.R. Hof Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease Neurology 60 2003 1495 1500
36. S.W. Scheff, D.A. Price, F.A. Schmitt, S.T. DeKosky, and E.J. Mufson Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment Neurology 68 2007 1501 1508
37. A. Serrano-Pozo, J. Qian, S.E. Monsell, M.P. Frosch, R.A. Betensky, and B.T. Hyman Examination of the clinicopathologic continuum of Alzheimer disease in the autopsy cohort of the National Alzheimer Coordinating Center J Neuropathol Exp Neurol 72 2013 1182 1192
38. C.M. Norris, I. Kadish, E.M. Blalock, K.-C. Chen, V. Thibault, N.M. Porter, P.W. Landfield, and S.D. Kraner Calcineurin triggers reactive/inflammatory processes in astrocytes and is upregulated in aging and Alzheimer's models J Neurosci 25 2005 4649 4658
39. H. Cho, T. Hashimoto, E. Wong, Y. Hori, L.B. Wood, L. Zhao, K.M. Haigis, B.T. Hyman, and D. Irimia Microfluidic chemotaxis platform for differentiating the roles of soluble and bound amyloid-β on microglial accumulation Sci Rep 3 2013 1823
40. P. Hollingworth, D. Harold, R. Sims, A. Gerrish, J.-C. Lambert, M.M. Carrasquillo, and et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease Nat Genet 43 2011 429 435
41. A.C. Naj, G. Jun, G.W. Beecham, L.-S. Wang, B.N. Vardarajan, J. Buros, and et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease Nat Genet 43 2011 436 441
42. R. Guerreiro, A. Wojtas, J. Bras, M. Carrasquillo, E. Rogaeva, E. Majounie, C. Cruchaga, C. Sassi, J.S. Kauwe, S. Younkin, L. Hazrati, J. Collinge, J. Pocock, T. Lashley, J. Williams, J.-C. Lambert, P. Amouyel, A. Goate, R. Rademakers, K. Morgan, J. Powell, P. St George-Hyslop, A. Singleton, J. Hardy Alzheimer Genetic Analysis Group TREM2 variants in Alzheimer's disease N Engl J Med 368 2013 117 127
43. T. Jonsson, H. Stefansson, S. Steinberg, I. Jonsdottir, P.V. Jonsson, J. Snaedal, S. Bjornsson, J. Huttenlocher, A.I. Levey, J.J. Lah, D. Rujescu, H. Hampel, I. Giegling, O.A. Andreassen, K. Engedal, I. Ulstein, S. Djurovic, C. Ibrahim-Verbaas, A. Hofman, M.A. Ikram, C.M. van Duijn, U. Thorsteinsdottir, A. Kong, and K. Stefansson Variant of TREM2 associated with the risk of Alzheimer's disease N Engl J Med 368 2013 107 116
44. J.-C. Lambert, S. Heath, G. Even, D. Campion, K. Sleegers, M. Hiltunen, and et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease Nat Genet 41 2009 1094 1099
45. E.M. Bradshaw, L.B. Chibnik, B.T. Keenan, L. Ottoboni, T. Raj, A. Tang, L.L. Rosenkrantz, S. Imboywa, M. Lee, A. Von Korff Alzheimer Disease Neuroimaging Initiative M.C. Morris, D.A. Evans, K. Johnson, R.A. Sperling, J.A. Schneider, D.A. Bennett, and P.L. De Jager CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology Nat Neurosci 16 2013 848 850
46. A. Griciuc, A. Serrano-Pozo, A.R. Parrado, A.N. Lesinski, C.N. Asselin, K. Mullin, B. Hooli, S.H. Choi, B.T. Hyman, and R.E. Tanzi Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta Neuron 78 2013 631 643
47. J.D. Ulrich, M.B. Finn, Y. Wang, A. Shen, T.E. Mahan, H. Jiang, F.R. Stewart, L. Piccio, M. Colonna, and D.M. Holtzman Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2 Mol Neurodegener 9 2014 20
48. Y. Wang, M. Cella, K. Mallinson, J.D. Ulrich, K.L. Young, M.L. Robinette, S. Gilfillan, G.M. Krishnan, S. Sudhakar, B.H. Zinselmeyer, D.M. Holtzman, J.R. Cirrito, and M. Colonna TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model Cell 160 2015 1061 1071
49. H. Crehan, J. Hardy, and J. Pocock Blockage of CR1 prevents activation of rodent microglia Neurobiol Dis 54 2013 139 149
50. P.I. Ortinski, J. Dong, A. Mungenast, C. Yue, H. Takano, D.J. Watson, P.G. Haydon, and D.A. Coulter Selective induction of astrocytic gliosis generates deficits in neuronal inhibition Nat Neurosci 13 2010 584 591
51. Z. Wu, Z. Guo, M. Gearing, and G. Chen Tonic inhibition in dentate gyrus impairs long-term potentiation and memory in an Alzheimer's disease model Nat Commun 5 2014 4159
52. S. Jo, O. Yarishkin, Y.J. Hwang, Y.E. Chun, M. Park, D.H. Woo, J.Y. Bae, T. Kim, J. Lee, H. Chun, H.J. Park, Y. Lee da, J. Hong, H.Y. Kim, S.-J. Oh, S.J. Park, H. Lee, B.-E. Yoon, Y. Kim, Y. Jeong, I. Shim, Y.C. Bae, J. Cho, N.W. Kowall, H. Ryu, E. Hwang, D. Kim, and C.J. Lee GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease Nat Med 20 2014 886 896
53. D. Ito, Y. Imai, K. Ohsawa, K. Nakajima, Y. Fukuuchi, and S. Kohsaka Microglia-specific localisation of a novel calcium binding protein, Iba1 Brain Res Mol Brain Res 57 1998 1 9
54. K. Kobayashi, F. Muramori, T. Aoki, M. Hayashi, K. Miyazu, Y. Fukutani, M. Mukai, and F. Koshino KP-1 is a marker for extraneuronal neurofibrillary tangles and senile plaques in Alzheimer diseased brains Dement Geriatr Cogn Disord 9 1998 13 19
55. G.W. Rebeck, J.S. Reiter, D.K. Strickland, and B.T. Hyman Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions Neuron 11 1993 575 580
56. D.E. Schmechel, A.M. Saunders, W.J. Strittmatter, B.J. Crain, C.M. Hulette, S.H. Joo, M.A. Pericak-Vance, D. Goldgaber, and A.D. Roses Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease Proc Natl Acad Sci U S A 90 1993 9649 9653
57. T. Polvikoski, R. Sulkava, M. Haltia, K. Kainulainen, A. Vuorio, A. Verkkoniemi, L. Niinistö, P. Halonen, and K. Kontula Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein N Engl J Med 333 1995 1242 1247
58. T. Gomez-Isla, H.L. West, G.W. Rebeck, S.D. Harr, J.H. Growdon, J.J. Locascio, T.T. Perls, L.A. Lipsitz, and B.T. Hyman Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease Ann Neurol 39 1996 62 70
59. P. Tiraboschi, L.A. Hansen, E. Masliah, M. Alford, L.J. Thal, and J. Corey-Bloom Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease Neurology 62 2004 1977 1983
60. A. Serrano-Pozo, J. Qian, S.E. Monsell, R.A. Betensky, and B.T. Hyman APOEε2 is associated with milder clinical and pathological Alzheimer disease Ann Neurol 77 2015 917 929
61. E. Cudaback, X. Li, K.S. Montine, T.J. Montine, and C.D. Keene Apolipoprotein E isoform-dependent microglia migration FASEB J 25 2011 2082 2091
62. Y. Zhu, E. Nwabuisi-Heath, S.B. Dumanis, L.M. Tai, C. Yu, G.W. Rebeck, and M.J. LaDu APOE genotype alters glial activation and loss of synaptic markers in mice Glia 60 2012 559 569
63. G.A. Rodriguez, L.M. Tai, M.J. LaDu, and G.W. Rebeck Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition J Neuroinflammation 11 2014 111
64. E. Cudaback, Y. Yang, T.J. Montine, and C.D. Keene APOE genotype-dependent modulation of astrocyte chemokine CCL3 production Glia 63 2015 51 65
65. A.W. Kraft, X. Hu, H. Yoon, P. Yan, Q. Xiao, Y. Wang, S.C. Gil, J. Brown, U. Wilhelmsson, J.L. Restivo, J.R. Cirrito, D.M. Holtzman, J. Kim, M. Pekny, and J.-M. Lee Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice FASEB J 27 2013 187 198
66. S.A. Grathwohl, R.E. Kälin, T. Bolmont, S. Prokop, G. Winkelmann, S.A. Kaeser, J. Odenthal, R. Radde, T. Eldh, S. Gandy, A. Aguzzi, M. Staufenbiel, P.M. Mathews, H. Wolburg, F.L. Heppner, and M. Jucker Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia Nat Neurosci 12 2009 1361 1363
67. S. Gilman, M. Koller, R.S. Black, L. Jenkins, S.G. Griffith, N.C. Fox, L. Eisner, L. Kirby, M.B. Rovira, F. Forette, J.-M. Orgogozo AN1792(QS-21)-201 Study Team Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial Neurology 64 2005 1553 1562
68. S. Salloway, R. Sperling, N.C. Fox, K. Blennow, W. Klunk, M. Raskind, M. Sabbagh, L.S. Honig, A.P. Porsteinsson, S. Ferris, M. Reichert, N. Ketter, B. Nejadnik, V. Guenzler, M. Miloslavsky, D. Wang, Y. Lu, J. Lull, I.C. Tudor, E. Liu, M. Grundman, E. Yuen, R. Black, H.R. Brashear Bapineuzumab 301 and 302 Clinical Trial Investigators Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease N Engl J Med 370 2014 322 333
69. R.S. Doody, R.G. Thomas, M. Farlow, T. Iwatsubo, B. Vellas, S. Joffe, K. Kieburtz, R. Raman, X. Sun, P.S. Aisen, E. Siemers, H. Liu-Seifert, R. Mohs Alzheimer's Disease Cooperative Study Steering Committee Solanezumab Study Group Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease N Engl J Med 370 2014 311 321
70. R.P. Brendza, B.J. Bacskai, J.R. Cirrito, K.A. Simmons, J.M. Skoch, W.E. Klunk, C.A. Mathis, K.R. Bales, S.M. Paul, B.T. Hyman, and D.M. Holtzman Anti-Abeta antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice J Clin Invest 115 2005 428 433
71. A. Rozkalne, T.L. Spires-Jones, E.A. Stern, and B.T. Hyman A single dose of passive immunotherapy has extended benefits on synapses and neurites in an Alzheimer's disease mouse model Brain Res 1280 2009 178 185
72. D. Boche, J. Donald, S. Love, S. Harris, J.W. Neal, C. Holmes, and J.A.R. Nicoll Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer's disease Acta Neuropathol 120 2010 13 20
73. E. Zotova, C. Holmes, D. Johnston, J.W. Neal, J.A. Nicoll, and D. Boche Microglial alterations in human Alzheimer's disease following Aβ42 immunization Neuropathol Appl Neurobiol 37 2011 513 524
74. E. Zotova, V. Bharambe, M. Cheaveau, W. Morgan, C. Holmes, S. Harris, J.W. Neal, S. Love, J.A. Nicoll, and D. Boche Inflammatory components in human Alzheimer's disease and after active amyloid-β42 immunization Brain 136 2013 2677 2696